Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.8200
-0.0100 (-1.20%)
Mar 11, 2026, 4:10 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 225.19 million as of March 10, 2026. Its market cap has decreased by -33.79% in one year.
Market Cap
225.19M
Enterprise Value
181.33M
Revenue
9.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.82
Market Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 225.19M, an increase of 658.20%. That is a compound annual growth rate of 19.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 225.19M | -23.50% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 582.12M |
| Clinuvel Pharmaceuticals | 510.04M |
| Racura Oncology | 447.04M |
| Dimerix | 243.16M |
| Tetratherix | 196.97M |
| Starpharma Holdings | 170.07M |
| Actinogen Medical | 150.18M |
| Recce Pharmaceuticals | 133.02M |